InsiderTrades

Form 4 for JAZZ Jazz Pharmaceuticals plc

Accepted 2021-10-06 00:00:00 ET · period of report 2021-10-04 · accession 0001765581-21-000120 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-10-06 2021-10-04 JAZZ COZADD BRUCE C COB, CEO, Dir S - Sale+OE $129.87 -6,598 312.4K -2% -$856.9K
D 2021-10-06 2021-10-04 JAZZ COZADD BRUCE C COB, CEO, Dir M - OptEx $46.83 +9,700 319.0K +3% +$454.3K
D 2021-10-06 2021-10-04 JAZZ COZADD BRUCE C COB, CEO, Dir M - OptEx $0.00 -9,700 96.9K -9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2021-10-04 S D 6,598 $129.87 312,392 D — —
2 Common Ordinary Shares 2021-10-04 M A 9,700 $46.83 318,990 D — —
3 Derivative Non-Qualified Stock Option (right to buy) 2021-10-04 M D 9,700 $0.00 96,932 D $46.83 · — to 2022-08-08 9,700 Ordinary Shares (F3) This Non-qualified stock option is part of an option granted on August 9, 2012. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.